Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
7 Safe Stocks to Rely on When the Market Swerves
01:10pm, Monday, 19'th Sep 2022
Back in August, I made the argument why now's the right time to buy safe stocks. Just over a month later, this continues to be the case.
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
06:00am, Friday, 02'nd Sep 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jacob Liawatidewi, Executive V.P. of Corporate Administration Center and Sale
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q2 2022 Results - Earnings Call Transcript
10:33pm, Monday, 08'th Aug 2022
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q2 2022 Results Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Dan Dischner - Vice President, Corporate Communications Bill Pete
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
08:20pm, Monday, 08'th Aug 2022
Amphastar (AMPH) delivered earnings and revenue surprises of 5.41% and 4.49%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Amphastar, Syndax Top Second-Quarter Estimates, But Runaway Biotechs At A Standstill
04:34pm, Monday, 08'th Aug 2022
Amphastar and Syndax, two top-rated biotech stocks, topped second-quarter estimates on Tuesday. But shares stayed flat.
Amphastar Pharmaceuticals: Compelling Growth Prospects For H2 2022 And Beyond
08:00am, Monday, 08'th Aug 2022
Amphastar currently has seven drugs under development, two drugs awaiting launch, and a base of over nine FDA-approved products in production. With the recent approval of generic ganirelix and vasopre
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022
06:05am, Monday, 01'st Aug 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 1, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2022 ended June 30, 2022, a
Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings
01:33pm, Tuesday, 26'th Jul 2022
Amphastar Pharmaceutcls is near a buy zone with earnings due on or around Aug. 9. The post Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings appeared first on Investor's Busine
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
06:05am, Monday, 06'th Jun 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, and Dan Dischner, V.P of Corporate Communicat
Amphastar Pharmaceuticals: Stock With An Attractive 6 To 1 Risk-Reward Ratio
02:22am, Friday, 13'th May 2022
Amphastar Pharmaceuticals has several key growth drivers: a strong pipeline of products currently awaiting approval, exciting products with growing sales, and growing marketing and distribution channe
7 Safe Small-Cap Stocks to Buy Now
10:25am, Thursday, 12'th May 2022
If you're looking for resilient plays with high upside potential, consider these seven safe small-cap stocks to buy. The post 7 Safe Small-Cap Stocks to Buy Now appeared first on InvestorPlace.
Has Amphastar Pharmaceuticals (AMPH) Outpaced Other Medical Stocks This Year?
01:40pm, Wednesday, 11'th May 2022 Zacks Investment Research
Here is how Amphastar Pharmaceuticals (AMPH) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Has Amphastar Pharmaceuticals (AMPH) Outpaced Other Medical Stocks This Year?
11:17am, Wednesday, 11'th May 2022
Here is how Amphastar Pharmaceuticals (AMPH) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Amphastar Pharmaceuticals (AMPH) Q1 2022 Earnings Call Transcript
09:00am, Tuesday, 10'th May 2022 The Motley Fool
AMPH earnings call for the period ending March 31, 2022.
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
10:05pm, Monday, 09'th May 2022 Zacks Investment Research
Amphastar (AMPH) delivered earnings and revenue surprises of 42.42% and 8.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
